Skip to main content

Prof. Dr. med. Petr Hrúz

Leitender Arzt Gastroenterologie/Hepatologie
Standort Universitätsspital Basel

 

Portrait
Portrait
Lebenslauf
Mitgliedschaften
Publikationen
Reviews
Lebenslauf

11/2019
Ernennung zum Titularprofessor, Universität Basel

seit 2019
Leitender Arzt Gastroenterologie/Hepatologie, Clarunis Universitäres Bauchzentrum Basel/
Standort Universitätsspital Basel

02/2015
Leitender Arzt Gastroenterologie/Hepatologie, Universitätsspital Basel

01/2010-01/2015
Resident and Senior Physician in Gastroenterology, Department of Gastroenterology and Hepatology, University Hospital of Basel

June 2012
FMH Gastroenterology and Hepatology

03/2007-12/2009
Post-Doc Research Fellowship University California San Diego, La Jolla, School of Medicine, Department of Gastroenterology; USA

March 2007
FMH Internal Medicine

04/2004-12/2006
Resident in Internal Medicine, University Polyclinic and Clinic A University Hospital of Basel      

11/2002-03/2004 

Research Fellow; Postgraduate Course for Experimental Medicine:
Department of Clinical Pharmacology and Toxicology, Department of Gastroenterology, University Hospital of Basel  

04/2002-10/2002
Research Fellow; Postgraduate Course for Experimental Medicine, University Hospital of Zürich

09/2000-03/2002
Resident in Internal Medicine, Clinic B, University Hospital of Basel

03/1999-08/2000
Resident in Urology, University Clinic of Urology, Inselspital Bern

01/1998-02/1999
Resident in Psychiatry, Psychiatric University Clinic Basel

1991-1997
Study of Medicine, University of Basel

 

Mitgliedschaften
  • American Gastroenterological Association (AGA)
  • Foederatio Medicorum Helveticorum (FMH)
  • Schweizerische Gesellschaft für Gastroenterologie (SGG)
  • Swiss Research and Communication Network on Inflammatory Bowel Disease (IBDnet)
Publikationen
  • Mecklenburg I, Reznik D, Fasler-Kan E, Drewe J, Beglinger C, Hruz P. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease. J Crohns Colitis. 2014; 8(11):1392-7
  • Kahn J, Bussmann C, Beglinger C, Straumann A, Hruz P. Exercise-induced chest pain: an atypical manifestation of Eosinophilic Esophagitis. Am J Med 2015; 128:196-9
  • Miehlke S*, Hruz P*, Vieth M, Bussmann C, von Arnim U, Bajbouj M, Schlag C, Madisch A, Fibbe C, Wittenburg H, Allescher HD, Reinshagen M, Schubert S, Tack J, Müller M, Krummenerl P, Arts J, Mueller R, Dilger K, Greinwald R, Straumann A. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut 2016;65:390-9 * contributed equally
  • Straumann A, Blanchard C, Radonjic-Hoesli S, Bussmann Ch, Hruz P, Safroneeva E, Simon D, Schoepfer AM, Simon HU. A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families. Allergy 2016;71:889-900
  • Navarini AA*, Hruz P*, Berger CT, Hou TZ, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg Sgier BC, Kämpe O, Burgener AV, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker LT, Heijnen I, Daikeler TD, Gebbers JO, Grimbacher B, Sansom DM, Jeker R, Hess C, Recher M. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. J Allergy Clin Immunol. Mar;139(3):1043-1046
  • * contributed equally
  • Steinert A, Linas I, Kaya B, Ibrahim M, Schlitzer A, Hruz P, Radulovic K, Terracciano L, Macpherson AJ, Niess JH. The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models. J Immunol. 2017;199:2507-84
  • Kaymak T, Moriconi F, Niess JH, Beglinger C, Hruz P. Low discontinuation rate of Infliximab treatment in steroid-dependent/refractory Crohn’s disease patients. Inflamm Intest Dis 2018: published online February 21st 2018
  • Safroneeva E, Saner C, Rossel JB, Golay D, Pittet V, Godat S, Diem S, Aepli P, Sawatzki M, Borovicka J, Burgmann K, Juillerat P, Netzer P, Sendensky A, Hruz P, Girardin M, Biedermann L, Greuter T, Vavricka S, Michetti P, Mueller C, Straumann A, Schoepfer A.M. on behalf of the Swiss EoE Cohort Study Group. Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS). Inflamm Intest Dis 2018: published online January 31st 2018
  • Schmaler M, Colone A, Spagnuolo J, Zimmermann M, Lepore M, Kalinichenko A, Bhatia S, Cottier F, Rutishauser T, Pavelka N, Egli A, Azzali E, Pieroni M, Costantino G, Hruz P, Sauer U, Mori L, De Libero G. Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation. Mucosal Immunol 2018; 11:1060-70
  • Fuchs S, Sawas N, Staedler N, Schubert DA, D'Andrea A, Zeiser R, Piali L, Hruz P*, Frei AP*. High-dimensional single-cell proteomics analysisidentifies immune checkpoint signatures and therapeutic targets in ulcerative colitis. Eur. J. Immunol. 2019. 49: 462–475
  • Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M.β6 -integrin serves as a novel serum tumor marker for colorectal carcinoma. Int J Cancer. 2019 Jan 17.
  • Grandinetti T, Biedermann L, Bussmann C, Straumann A, Hruz P. Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course and Evaluation of Treatment with Corticosteroids and Vedolizumab. Dig Dis Sci. 2019 Apr 13. doi: 10.1007/s10620-019-05617-3.
Reviews
  • Hruz P, Straumann A Chapter 3: Epidemiology of Eosinophilic Esophagitis in Adults. C.A. Liacouras and J.E. Markowitz (eds.), Eosinophilic Esophagitis, Clinical Gastroenterology, 2012, 25-38 (Book chapter)
  • Hruz P. Epidemiology of eosinophilic esophagitis. Dig Dis. 2014;32:40-7 (Review)
  • Hruz P. Epidemiology of Eosinophilic Esophagitis. Unimed 2014 (Book chapter)
  • Niess JH, Hruz P, Kaymak T. The Interleukin-20 Cytokines in Intestinal Diseases. Front Immunol. 2018 Jun 18;9:1373.
  • Niess JH, Kaymak T, Hruz P. The Role of the Exposome in the Emergence of Chronic Inflammatory Bowel Diseases. Ther Umsch. 2019 Jan;75:261-270.